Camilo Gomez Restrepo

3 ta ish

Médecins Sans Frontières , Tashkent ,

1. A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020

   Michael L. Rekart, Phone Thit, Modupe Oluya +14

   Sharh maqolaTuberculosis Research and EpidemiologyIJTLD OPEN20240 iqtibos

   ABIABI:AkademIndex/openalex/2024.review-article.000146

2. The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and Uzbekistan

   Animesh A. Sinha, Robert J. Klebe, Michael L. Rekart +22

   MaqolaTuberculosis Research and EpidemiologyClinical Infectious Diseases20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.article.000230

3. Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis

   Anthony J. Garcia‐Prats, Maria Garcia‐Cremades, Vivian Cox +97

   Sharh maqolaTuberculosis Research and EpidemiologyThe Lancet Child & Adolescent Health20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.review-article.000036